IQVIA Holdings Inc

Chart & Performance

D1W1MN

P/E

26.73

P/S

2.42

EPS

7.48

Div Yield, %

0.00%

Shrs. gr., 5y

-2.20%

Rev. gr., 5y

7.55%

Revenues

14.98b

+3.98%

Net income

1.36b

+24.47%

CFO

2.15b

-4.91%

Earnings

Feb 12, 2025

Profile

IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; virtual trials; and strategic planning and design services, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a strategic collaboration with HealthCore, Inc. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was founded in 1982 and is headquartered in Durham, North Carolina.

URL

https://ir.iqvia.com/

IPO date

May 09, 2013

Employees

87,000

Domiciled in

Incorporated in

Valuation

Order:

Title USD in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY	FY	FY	FY
Title USD in thousands, except ratios and share amounts	2023‑12	2022‑12	2021‑12	2020‑12	2019‑12	2018‑12	2017‑12	2016‑12	2015‑12	2014‑12
Income
Revenues	14,984,000 3.98%	14,410,000 3.86%	13,874,000 22.14%
Cost of revenue	9,745,000	9,382,000	9,233,000
Unusual Expense (Income)
NOPBT	5,239,000	5,028,000	4,641,000
NOPBT Margin	34.96%	34.89%	33.45%
Operating Taxes	101,000	260,000	163,000
Tax Rate	1.93%	5.17%	3.51%
NOPAT	5,138,000	4,768,000	4,478,000
Net income	1,358,000 24.47%	1,091,000 12.94%	966,000 246.24%
Dividends
Dividend yield
Proceeds from repurchase of equity	(992,000)	(1,168,000)	(465,000)
BB yield	2.30%	2.99%	0.85%
Debt
Debt current	825,000	152,000	91,000
Long-term debt	13,857,000	13,123,000	12,660,000
Deferred revenue		464,000
Other long-term liabilities	470,000	207,000	649,000
Net debt	12,947,000	11,804,000	11,110,000
Cash flow
Cash from operating activities	2,149,000	2,260,000	2,942,000
CAPEX	(649,000)	(674,000)	(640,000)
Cash from investing activities	(1,603,000)	(2,006,000)	(2,103,000)
Cash from financing activities	(382,000)	(329,000)	(1,235,000)
FCF	4,737,000	4,866,000	4,915,000
Balance
Cash	1,496,000	1,309,000	1,477,000
Long term investments	239,000	162,000	164,000
Excess cash	985,800	750,500	947,300
Stockholders' equity	3,828,000	13,505,000	12,614,000
Invested Capital	19,827,200	18,535,500	18,044,700
ROIC	26.79%	26.07%	24.70%
ROCE	24.93%	25.46%	23.92%
EV
Common stock shares outstanding	186,300	190,600	195,000
Price	231.38 12.93%	204.89 -27.38%	282.14 57.47%
Market cap	43,106,094 10.38%	39,052,034 -29.02%	55,017,300 57.47%
EV	56,053,094	50,856,034	66,127,300
EBITDA	6,364,000	6,158,000	5,905,000
EV/EBITDA	8.81	8.26	11.20
Interest	672,000	416,000	375,000
Interest/NOPBT	12.83%	8.27%	8.08%